04:26
Unknown
Ranbaxy Laboratories is reportedly in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca Plc’s heartburn drug Nexium, after a US ban on shipments from a plant in India. Nexium had global sales last year of $3.87 billion.
For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI
Posted in: Indian Market Tips
0 comments:
Post a Comment